Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects
A Prospective, Randomized, Double-Blind Parallel-group, Non-inferiority Phase II/III Study of the Safety and Effectiveness of BPL HRIG With Co Administration of Active Rabies Vaccine in Healthy Subjects
Sponsor: Bio Products Laboratory
A PHASE2/PHASE3 clinical study on Healthy, this trial is completed. The trial is conducted by Bio Products Laboratory and has accumulated 14 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2_PHASE3
▶ Show 9 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Dec 2019 — Mar 2020 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Aug 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Apr 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Aug 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Feb 2018 — Mar 2018 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Feb 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bio Products Laboratory
For direct contact, visit the study record on ClinicalTrials.gov .